Recorded fact · drug.label_indication
drug.label_indication for omalizumab|chronic-spontaneous-urticaria
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact cd72dd37 resolves to.
The record
| Fact id | cd72dd374054383c8d116178 |
|---|---|
| Entity | drug: omalizumab|chronic-spontaneous-urticaria |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20260813 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Chronic spontaneous urticaria (CSU) in adults and adolescents 12 years of age and older who remain symptomatic despite H1 antihistamine treatment ( 1.
Shown with dashes as hyphens. SHA-256 of the exact stored quote: 4d190aabddb42f91d1418c1f7228e296f684e2d4eb79f437434853fa2044b9ae.
The value
{
"ingredient": "OMALIZUMAB",
"conditionId": "chronic-spontaneous-urticaria",
"conditionName": "Chronic spontaneous urticaria",
"matchedAlias": "Chronic spontaneous urticaria",
"context": "indication",
"brand": "XOLAIR",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "7f6a2191-adfb-48b9-9bfa-0d9920479f0d",
"labelEffectiveTime": "20260813",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: c74cedc5119ff3fa55ad0c24ba2d341564a8395576d03dd967c2320ee90ac874.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.